R ROMAN¹, M VERDU^1,3, A VIDAL^3,5, M CALVO⁴, X SANJUAN⁵, M JIMENO⁶, A SALAS⁷, J AUTONELL⁸, I TRIAS⁹, N RODON¹, M GONZALEZ¹, B GARCIA¹ and X PUIG^1,2,3.

¹BIOPAT.Biopatologia Molecular, Barcelona, Spain; ²Hospital de Barcelona, Barcelona, Spain; ³Histopat Laboratoris, Barcelona, Spain; ⁴Statistics Department, Universitat de Barcelona, Barcelona, Spain; ⁵Hospital Universitari de Bellvitge, Barcelona, Spain; ⁶Hospital del Mar, […]

Ruth Roman¹, Montse Verdú ^1,3, August Vidal ^1,3, Miquel Calvo ⁴, Natalia Rodón¹, Beatriz García¹, Marta González¹ and Xavier Puig^1,2,3.

¹BIOPAT. Biopatologia Molecular, SL, Grup Assistencia; ²Hospital de Barcelona SCIAS, Grup Assistència; ³Histopat Laboratoris and ⁴Statistics Department, Universitat de Barcelona. Barcelona, Spain.

INTRODUCTION: Invasive micropapillary carcinoma (MC) is associated with frequent lymph node metastasis and adverse clinical […]

Roman R,¹ Colomer A,¹ Erill N,¹ Verdú M,² Ibáñez R,¹ Cordon-Cardo C,¹ Puig X.^1,2

¹BIOPAT. Biopatologia Molecular, Grup Assistència & ²HISTOPAT Laboratoris, Barcelona, Catalonia, Spain.

Background: Irinotecan (CPT-11) is currently used as first- or second-line treatment for colorectal cancer, either alone or in combination with 5-fluorouracil based regimens. UDP-glucuronosyltransferase 1A1 (UGT1A1) catalyzes the inactivation of SN-38, the […]